Lean on Me: Specialty Pharmacist Provision of Supportive Care in Oncology (Pharmacist)
Lean on Me: Specialty Pharmacist Provision of Supportive Care in Oncology (Pharmacist)
Patients with a cancer diagnosis have numerous burdens to bear – emotional distress, physical barriers – including adverse drug events, financial hardships, and mental exhaustion … just to name a few. Yet sometimes, the best interventions for patients with cancer come from a specialty pharmacist and their team in the form of supportive care. This course will review the most common ailments experienced by patients prescribed oral oncolytic medications as treatment for cancer and the numerous ways in which clinical pharmacy teams can mitigate these adverse drug events. Also, we will discuss how a specialty pharmacist can anticipate and prevent adverse events associated with oral oncolytic medications with thorough prospective and retrospective drug utilization reviews. If you need a refresher on how to keep your patients with cancer feeling fresh, this course is for you.
Upon successful completion of this application-based CPE course, pharmacists should be able to:
1. List five of the most common adverse events patients with cancer experience while taking an oral oncolytic
2. Discuss opportunities for the specialty pharmacist to anticipate adverse events associated with an oral oncolytic
3. Compare and contrast pharmacologic vs. nonpharmacologic therapy options to treat oral oncolytic medication-related adverse events and their appropriate use in patients with cancer
4. Describe the actions a specialty pharmacist can take to help alleviate or eliminate adverse events associated with an oral oncolytic medication
5. Create a supportive care plan for a patient with cancer suffering from an oral oncolytic induced adverse event(s)
Kelly M. Brunk, Pharm.D., BCOP
Clinical Pharmacist
University of Kansas Health System
Kelly Brunk does not report any actual or potential conflicts of interest in relation to this continuing pharmacy education course.
Financial support was provided for this course through an unrestricted educational grant from Biologics by McKesson.
Course includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable
Initial Release Date: July 27, 2021
Planned Expiration Date: July 27, 2024
Copyright 2021, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.
RV3-4.24/EXP
CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at www.MyCPEMonitor.net.
¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.
Additional information
| Duration | 1h 0m |
|---|---|
| Topic Designator | Disease State/Drug Therapy |
| ACPE | Yes |
| ACPE Topic | 01 Drug Therapy |
| Role | Pharmacist |
| Media-Type | On-Demand |
| Release Date | 7/27/21 |
| CEUs | 0.1 |
| Rating | 4 |
| ACPE Number | 0107-0000-21-240-H01-P |
